An Open-Label Study to Evaluate "Completeness of Response" Following Treatment With Treximet for Migraine.
Phase of Trial: Phase IV
Latest Information Update: 24 Jan 2011
At a glance
- Drugs Naproxen sodium/sumatriptan; Tryptamines
- Indications Migraine
- Focus Therapeutic Use
- 23 Jun 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 23 Jun 2010 Actual end date (Jan 2010) added as reported by ClinicalTrials.gov.
- 23 Jun 2010 Actual patient number (147) added as reported by ClinicalTrials.gov.